Randomized controlled trial of intravenous acetaminophen vs intravenous hydromorphone for the treatment of acute pain in the Emergency Department
Does co-treatment with ultra-low-dose naloxone and morphine provide better analgesia in renal colic patients?
Implementation of an opioid detoxification management pathway reduces Emergency Department length of stay
3 reasons to join M3 India Market Research Panel
- Contribute to improvements in Healthcare by sharing your insights
- Earn rewards in your free time
- Secure: We never share your personal information without your permission
Over 4 million Doctors across 9 countries
trust M3 Group for their daily practice.
M3 India is a Joint Venture between M3 Inc. Japan and Health Care at Home India Pvt. Ltd.
By leveraging internet based technologies, this initiative will expand access to information and enhance communication in the Indian healthcare sector.